Free Trial

Bioventus (BVS) News Today

Bioventus logo
$7.03 -0.31 (-4.22%)
Closing price 04:00 PM Eastern
Extended Trading
$7.02 0.00 (-0.07%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Bioventus Inc. stock logo
Marshall Wace LLP Sells 307,404 Shares of Bioventus Inc. (NYSE:BVS)
Marshall Wace LLP reduced its holdings in Bioventus Inc. (NYSE:BVS - Free Report) by 80.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 73,423 shares of the company's stock after selling 307,404 shares during the quarter. Marshall Wace LLP owne
Bioventus Inc. stock logo
Nantahala Capital Management LLC Sells 324,061 Shares of Bioventus Inc. (NYSE:BVS)
Nantahala Capital Management LLC lessened its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 7.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,026,809 shares of the company's stock after selli
Bioventus Inc. stock logo
Oberweis Asset Management Inc. Buys 90,800 Shares of Bioventus Inc. (NYSE:BVS)
Oberweis Asset Management Inc. grew its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 17.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 601,714 shares of the company's stock after acq
Bioventus Inc. stock logo
JPMorgan Chase & Co. Acquires 45,390 Shares of Bioventus Inc. (NYSE:BVS)
JPMorgan Chase & Co. raised its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 17.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 299,130 shares of the company's stock after acquiring an add
Bioventus Inc. stock logo
Bioventus Inc. (NYSE:BVS) SVP Anthony D'adamio Sells 2,958 Shares
Bioventus Inc. (NYSE:BVS - Get Free Report) SVP Anthony D'adamio sold 2,958 shares of the company's stock in a transaction on Friday, April 11th. The shares were sold at an average price of $7.57, for a total value of $22,392.06. Following the completion of the sale, the senior vice president now directly owns 131,416 shares in the company, valued at $994,819.12. This trade represents a 2.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Bioventus Inc. stock logo
Insider Selling: Bioventus Inc. (NYSE:BVS) CFO Sells 3,875 Shares of Stock
Bioventus Inc. (NYSE:BVS - Get Free Report) CFO Mark Leonard Singleton sold 3,875 shares of the stock in a transaction dated Friday, April 11th. The stock was sold at an average price of $7.57, for a total transaction of $29,333.75. Following the transaction, the chief financial officer now owns 141,088 shares of the company's stock, valued at $1,068,036.16. This represents a 2.67 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Bioventus Inc. stock logo
Kennedy Capital Management LLC Boosts Stock Position in Bioventus Inc. (NYSE:BVS)
Kennedy Capital Management LLC raised its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 80.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 213,984 shares of the company's stoc
Bioventus Inc. stock logo
Bioventus Inc. (NYSE:BVS) Shares Bought by Franklin Resources Inc.
Franklin Resources Inc. increased its holdings in Bioventus Inc. (NYSE:BVS - Free Report) by 56.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 126,140 shares of the company's stock after buying an additional 45,728 shares during the period. Franklin Reso
Bioventus Inc. stock logo
Bioventus Inc. (NYSE:BVS) Shares Acquired by Vanguard Group Inc.
Vanguard Group Inc. boosted its stake in Bioventus Inc. (NYSE:BVS - Free Report) by 18.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,462,081 shares of the company's stock after acquiring
Bioventus Inc. stock logo
Trexquant Investment LP Has $467,000 Stock Holdings in Bioventus Inc. (NYSE:BVS)
Trexquant Investment LP reduced its position in Bioventus Inc. (NYSE:BVS - Free Report) by 56.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 44,471 shares of the company's stock after selling 58,493 shares during the period. Trexquant Investment LP owned abo
Bioventus Inc. stock logo
Prudential Financial Inc. Has $927,000 Stock Position in Bioventus Inc. (NYSE:BVS)
Prudential Financial Inc. grew its stake in Bioventus Inc. (NYSE:BVS - Free Report) by 650.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 88,260 shares of the company's stock after purchasing an additiona
Bioventus Inc. stock logo
American Century Companies Inc. Buys 246,645 Shares of Bioventus Inc. (NYSE:BVS)
American Century Companies Inc. raised its holdings in Bioventus Inc. (NYSE:BVS - Free Report) by 38.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 884,673 shares of the company's stock after buying an additional 246,
Bioventus Inc. stock logo
70,500 Shares in Bioventus Inc. (NYSE:BVS) Acquired by Swiss National Bank
Swiss National Bank bought a new position in Bioventus Inc. (NYSE:BVS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 70,500 shares of the company's stock, valued at approximately $740,000. Swiss National Bank o
Bioventus Inc. stock logo
Insider Selling: Bioventus Inc. (NYSE:BVS) CFO Sells 5,479 Shares of Stock
Bioventus Inc. (NYSE:BVS - Get Free Report) CFO Mark Leonard Singleton sold 5,479 shares of the company's stock in a transaction on Monday, March 24th. The stock was sold at an average price of $9.79, for a total value of $53,639.41. Following the sale, the chief financial officer now owns 131,963 shares of the company's stock, valued at $1,291,917.77. This trade represents a 3.99 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Bioventus Inc. stock logo
Charles Schwab Investment Management Inc. Grows Position in Bioventus Inc. (NYSE:BVS)
Charles Schwab Investment Management Inc. grew its holdings in Bioventus Inc. (NYSE:BVS - Free Report) by 11.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 435,344 shares of the company's stock after buying an addition
Bioventus Inc. stock logo
Sheets Smith Investment Management Buys Shares of 142,723 Bioventus Inc. (NYSE:BVS)
Sheets Smith Investment Management bought a new stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 142,723 shares of the company's stock, valued at approximately $1,499,000. Bioventus accounts
Bioventus Inc. stock logo
Summit Global Investments Makes New Investment in Bioventus Inc. (NYSE:BVS)
Summit Global Investments acquired a new stake in Bioventus Inc. (NYSE:BVS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 52,675 shares of the company's stock, valued at approximately $553,000. Summit Global Investme
Bioventus Inc. stock logo
Bioventus Inc. (NYSE:BVS) Shares Bought by Bank of New York Mellon Corp
Bank of New York Mellon Corp boosted its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 37.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 125,055 shares of the company's stock after acquiring an additional
Bioventus Inc. stock logo
Bioventus Inc. (NYSE:BVS) Position Increased by Royce & Associates LP
Royce & Associates LP boosted its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 5.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 732,236 shares of the company's stock after buying an additiona
Bioventus Inc. stock logo
Connor Clark & Lunn Investment Management Ltd. Sells 62,577 Shares of Bioventus Inc. (NYSE:BVS)
Connor Clark & Lunn Investment Management Ltd. lessened its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 24.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 196,179 shares of the company's stock after selling
Bioventus Inc. stock logo
Canaccord Genuity Group Reiterates Buy Rating for Bioventus (NYSE:BVS)
Canaccord Genuity Group reaffirmed a "buy" rating and issued a $15.00 price objective on shares of Bioventus in a research note on Monday.
Bioventus Inc. stock logo
AlphaQuest LLC Increases Stock Holdings in Bioventus Inc. (NYSE:BVS)
AlphaQuest LLC raised its position in Bioventus Inc. (NYSE:BVS - Free Report) by 810.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,764 shares of the company's stock after acquiring an additiona
Bioventus Inc. stock logo
Bioventus (NYSE:BVS) Trading Down 5.9% - Here's Why
Bioventus (NYSE:BVS) Stock Price Down 5.9% - Here's What Happened
Bioventus Inc. stock logo
Bioventus (NYSE:BVS) Shares Gap Up - Still a Buy?
Bioventus (NYSE:BVS) Shares Gap Up - Still a Buy?
Bioventus Inc. stock logo
Bioventus (NYSE:BVS) Updates FY 2025 Earnings Guidance
Bioventus (NYSE:BVS) updated its FY 2025 earnings guidance. The company provided EPS guidance of 0.640-0.680 for the period, compared to the consensus estimate of 0.550. The company also issued revenue guidance of $560.0 millionillion-$570.0 millionillion, compared to the consensus estimate of $554.8 millionillion.
Bioventus Shares Rise After Improved 4Q
Bioventus reports Q4 non-GAAP EPS 15c, consensus 8c
Bioventus sees FY25 revenue $560M-$570M, consensus $554.78M
Craig-Hallum Reaffirms Their Buy Rating on Bioventus (BVS)
Bioventus Inc. stock logo
Los Angeles Capital Management LLC Sells 43,144 Shares of Bioventus Inc. (NYSE:BVS)
Los Angeles Capital Management LLC trimmed its stake in Bioventus Inc. (NYSE:BVS - Free Report) by 30.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 100,320 shares of the company's stock after selling 43,144
Bioventus Inc. stock logo
Bioventus Inc. (NYSE:BVS) SVP Sells $44,632.20 in Stock
Bioventus Inc. (NYSE:BVS - Get Free Report) SVP Anthony D'adamio sold 4,380 shares of the company's stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $10.19, for a total transaction of $44,632.20. Following the completion of the transaction, the senior vice president now directly owns 118,178 shares in the company, valued at approximately $1,204,233.82. The trade was a 3.57 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Bioventus Inc. stock logo
Mark Leonard Singleton Sells 6,498 Shares of Bioventus Inc. (NYSE:BVS) Stock
Bioventus Inc. (NYSE:BVS - Get Free Report) CFO Mark Leonard Singleton sold 6,498 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $10.19, for a total value of $66,214.62. Following the completion of the transaction, the chief financial officer now owns 118,817 shares of the company's stock, valued at $1,210,745.23. The trade was a 5.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Bioventus Inc. stock logo
Stephens Inc. AR Sells 28,925 Shares of Bioventus Inc. (NYSE:BVS)
Stephens Inc. AR decreased its stake in Bioventus Inc. (NYSE:BVS - Free Report) by 51.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,775 shares of the company's stock after selling 28,925 shares duri
Bioventus Inc. stock logo
Spire Wealth Management Buys New Position in Bioventus Inc. (NYSE:BVS)
Spire Wealth Management purchased a new position in shares of Bioventus Inc. (NYSE:BVS - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 38,243 shares of the company's stock, valued
Bioventus Inc. stock logo
JPMorgan Chase & Co. Raises Position in Bioventus Inc. (NYSE:BVS)
JPMorgan Chase & Co. lifted its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 228.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 253,740 shares of the company's stock after purchasing an additional
Bioventus Inc. stock logo
Robert E. Claypoole Sells 28,786 Shares of Bioventus Inc. (NYSE:BVS) Stock
Bioventus Inc. (NYSE:BVS - Get Free Report) CEO Robert E. Claypoole sold 28,786 shares of the business's stock in a transaction on Monday, January 13th. The stock was sold at an average price of $9.10, for a total value of $261,952.60. Following the sale, the chief executive officer now owns 64,964 shares of the company's stock, valued at approximately $591,172.40. The trade was a 30.71 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Craig-Hallum Issues a Buy Rating on Bioventus (BVS)
Bioventus: Amply Rewarded For Recent Progress
Get Bioventus News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter.

BVS Media Mentions By Week

BVS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BVS
News Sentiment

1.32

0.72

Average
Medical
News Sentiment

BVS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BVS Articles
This Week

2

2

BVS Articles
Average Week

Get Bioventus News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:BVS) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners